Canadian Antimicrobial Innovation Coalition (CAIC)
@CanadaAMR
We aim to help protect Canadians from the rise in #AntimicrobialResistance (AMR) by positioning Canada to be a leader in #AMR research & product development.
We‘ve topped the Access to Medicine Index's 2026 Antimicrobial Resistance Benchmark, reflecting our continuous focus on delivering innovative antibiotic medicines and vaccines for patients with significant unmet medical need.
Check out our #AMR podcast: https://t.co/6xdcgVfJ32
It’s World AMR Awareness Week! Antimicrobial resistance is a global health crisis.
CIHR has invested $96.3 M over the past 5 years to support multidisciplinary AMR programs and research in Canada and around the world.
Learn more: https://t.co/9NrRSEHbpb
#WAAW#OneHealth
Our Chair, Dr. Sameeh Salama, CSO of Fedora Pharmaceuticals, was honoured to serve as a witness before the Standing Committee on Science and Research as part of the committee’s study on Antimicrobial Resistance. Tune in:
Our Chair, Dr. Sameeh Salama, CSO of Fedora Pharmaceuticals, was honoured to serve as a witness before the Standing Committee on Science and Research as part of the committee’s study on Antimicrobial Resistance. Learn more:
https://t.co/Bj1S9U1fhc
We were thrilled to be part of the AMR High Level Meeting in Ottawa. Thank you @SenatorRavalia, fellow Senators, MPs, esteemed speakers & guests. While Canada did not host a Health Minister’s meeting this year, #AMR is a priority topic for the #G7. More: https://t.co/WMio8kEUKr
Superbugs are on the rise—and the market for new antibiotics is broken. BIO’s Emily Wheeler highlights the urgent need for policy solutions like the PASTEUR Act to ensure doctors have tools to fight drug-resistant infections. Learn more: https://t.co/OaB7ZLI4bt
Canada must put together plan to tackle sepsis, researchers warn - It’s a sudden, silent killer that some nurses and doctors are ill prepared to diagnose, according to a group of Canadian researchers. https://t.co/JcJ3EKtj99
On the latest episode of the #AMR Action Podcast, @CMicetich, President & CEO of @brass_dome & @FedoraPharma, shares the current state of antimicrobial
innovation within the biotech industry and the challenges faced in developing new solutions. Tune in: https://t.co/h464Sbavm3
Ahead of the @AMMICanada@CACMID Annual Conference in Calgary, Christopher Micetich @CMicetich, joined the #AMR Action Podcast to talk about #Alberta’s leadership in Antimicrobial Resistance. Tune in to the full episode:
https://t.co/fzoY9HLfdi
“Often referred to as the ‘silent pandemic’, antimicrobial resistance is a particularly concerning public health threat. It represents an area where Canada has an opportunity to not only ensure preparedness, but also emerge as a global leader.”
Read the new op-ed from @gskca’s Alison Pozzobon: ‘Canada’s G7 presidency is a critical moment to tackle AMR’
https://t.co/IqwYAa5TPn via @thehilltimes
“Canada should use its presidency to action its Pan-Canadian Action Plan on Antimicrobial Resistance, and move the world from discourse to action by launching a national pull incentive designed to fit within our federal-provincial-territorial health system.”
New op-ed by @AMRActionFund’s Henry Skinner & @innovativemeds’ Bettina Hamelin: ‘Canada must not delay action on antimicrobial resistance’ “Canada is uniquely positioned to act as it prepares to assume the G7 presidency in January 2025”
https://t.co/4I8FfN0H6T via @thehilltimes
“Governments around the world know that delaying action is no longer an option. Canada has an opportunity to lead and fulfill its obligations to current and future generations.”